RVX-208 a Selective Bromodomain and Extra-terminal BET Protein Inhibitor Acts on Several Pathways to Benefit Cardiovascular Risks

被引：0
|
作者：
Wong, Norman C.
Kulikowski, Ewelina
Wasiak, Sylwia
Gilham, Dean
Halliday, Christopher
Lebioda, Kenneth
Sweeney, Mike
Johansson, Jan
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
Epigenetics; Inflammation; Complement HDL; Acute phase reactants;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17127
引用
收藏
页数：4
相关论文
共 50 条
  • [31] GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
    Preston, Alex
    Atkinson, Stephen J.
    Bamborough, Paul
    Chung, Chun-wa
    Gordon, Laurie J.
    Grandi, Paola
    Gray, James R. J.
    Harrison, Lee A.
    Lewis, Antonia J.
    Lugo, David
    Messenger, Cassie
    Michon, Anne-Marie
    Mitchell, Darren J.
    Prinjha, Rab K.
    Rioja, Inmaculada
    Seal, Jon
    Taylor, Simon
    Thesmar, Pierre
    Wall, Ian D.
    Watson, J.
    Woolven, James M.
    Demont, Emmanuel H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (08): : 1581 - 1587
  • [32] Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
    Albrecht, Brian K.
    Gehling, Victor S.
    Hewitt, Michael C.
    Vaswani, Rishi G.
    Cote, Alexandre
    Leblanc, Yves
    Nasveschuk, Christopher G.
    Bellon, Steve
    Bergeron, Louise
    Campbell, Robert
    Cantone, Nico
    Cooper, Michael R.
    Cummings, Richard T.
    Jayaram, Hariharan
    Joshi, Shivangi
    Mertz, Jennifer A.
    Neiss, Adrianne
    Normant, Emmanuel
    O'Meara, Michael
    Pardo, Eneida
    Poy, Florence
    Sandy, Peter
    Supko, Jeffrey
    Sims, Robert J., III
    Harmange, Jean-Christophe
    Taylor, Alexander M.
    Audia, James E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1330 - 1339
  • [33] Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
    Liu, Suhu
    Walker, Sarah R.
    Nelson, Erik A.
    Cerulli, Robert
    Xiang, Michael
    Toniolo, Patricia A.
    Qi, Jun
    Stone, Richard M.
    Wadleigh, Martha
    Bradner, James E.
    Frank, David A.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1194 - 1205
  • [34] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Wasiak, Sylwia
    Dzobo, Kim E.
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Bahjat, Mahnoush
    Stotz, Stephanie C.
    Fu, Li
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C. W.
    Stroes, Erik S. G.
    Kroon, Jeffrey
    Kulikowski, Ewelina
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [35] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Sylwia Wasiak
    Kim E. Dzobo
    Brooke D. Rakai
    Yannick Kaiser
    Miranda Versloot
    Mahnoush Bahjat
    Stephanie C. Stotz
    Li Fu
    Michael Sweeney
    Jan O. Johansson
    Norman C. W. Wong
    Erik S. G. Stroes
    Jeffrey Kroon
    Ewelina Kulikowski
    Clinical Epigenetics, 2020, 12
  • [36] Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors
    Wadhwa, Elizabeth
    Nicolaides, Theodore
    CUREUS, 2016, 8 (05):
  • [37] Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function
    Pinz, Sophia
    Unser, Samy
    Buob, Dominik
    Fischer, Philipp
    Jobst, Belinda
    Rascle, Anne
    NUCLEIC ACIDS RESEARCH, 2015, 43 (07) : 3524 - 3545
  • [38] RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease (vol 247, pg 48, 2016)
    Gilham, Dean
    Wasiak, Sylwia
    Tsujikawa, Laura M.
    Halliday, Christopher
    Norek, Karen
    Patel, Reena G.
    Kulikowski, Ewelina
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman C. W.
    ATHEROSCLEROSIS, 2016, 253 : 345 - 345
  • [39] Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors
    Hu, Jianping
    Tian, Chang-Qing
    Damaneh, Mohammadali Soleimani
    Li, Yanlian
    Cao, Danyan
    Lv, Kaikai
    Yu, Ting
    Meng, Tao
    Chen, Danqi
    Wang, Xin
    Chen, Lin
    Li, Jian
    Song, Shan-Shan
    Huan, Xia-Juan
    Qin, Lihuai
    Shen, Jingkang
    Wang, Ying-Qing
    Miao, Ze-Hong
    Xiong, Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (18) : 8642 - 8663
  • [40] Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
    Gilham, Dean
    Smith, Audrey L.
    Fu, Li
    Moore, Dalia Y.
    Muralidharan, Abenaya
    Reid, St. Patrick M.
    Stotz, Stephanie C.
    Johansson, Jan O.
    Sweeney, Michael
    Wong, Norman C. W.
    Kulikowski, Ewelina
    El-Gamal, Dalia
    BIOMEDICINES, 2021, 9 (04)
12345